speb/financial-data huggingface dataset:
CYRX balance_sheet (annual, 2024-12-31) — Gross PPE: 157710000.00
CYRX income_statement (annual, 2024-12-31) — Gross Profit: 69657000.00
CYRX income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 63809000.00
CYRX income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
CYRX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 1422000.00
CYRX income_statement (annual, 2024-12-31) — Interest Expense: 3977000.00
CYRX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3977000.00
CYRX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2693000.00
CYRX balance_sheet (annual, 2024-12-31) — Inventory: 21476000.00
CYRX balance_sheet (annual, 2024-12-31) — Invested Capital: 567097000.00
CYRX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 176815000.00
CYRX balance_sheet (annual, 2024-12-31) — Land And Improvements: 813000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 813000.00
CYRX balance_sheet (annual, 2024-12-31) — Leases: 34768000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Leases: 34768000.00
CYRX balance_sheet (annual, 2024-12-31) — Liabilities Heldfor Sale Non Current: 7797000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Liabilities Heldfor Sale Non Current: 7797000.00
CYRX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 39351000.00
CYRX balance_sheet (annual, 2024-12-31) — Long Term Debt: 185033000.00
CYRX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 224384000.00
CYRX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -164321000.00
CYRX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 26575000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 26575000.00
CYRX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -313000.00
CYRX cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -18000.00
CYRX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CYRX balance_sheet (annual, 2024-12-31) — Net Debt: 165337000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Net Debt: 165337000.00
CYRX income_statement (annual, 2024-12-31) — Net Income: -114756000.00
CYRX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -122756000.00
CYRX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -104708000.00
CYRX income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: -10048000.00
CYRX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -114756000.00
CYRX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -104708000.00
CYRX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -114756000.00
CYRX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -114756000.00
CYRX cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -4013000.00
CYRX income_statement (annual, 2024-12-31) — Net Interest Income: -3977000.00
CYRX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 198395000.00
CYRX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -164321000.00
CYRX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -164321000.00
CYRX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3977000.00
CYRX balance_sheet (annual, 2024-12-31) — Net PPE: 119933000.00
CYRX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -17254000.00
CYRX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 233402000.00
CYRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 842000.00
CYRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 804000.00
CYRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 842000.00
CYRX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 804000.00
CYRX balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 1951000.00
CYRX income_statement (annual, 2024-12-31) — Normalized EBITDA: -34206000.00
CYRX income_statement (annual, 2024-12-31) — Normalized Income: -76734890.00
CYRX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -16323000.00
CYRX cash_flow (annual, 2024-12-31) — Operating Gains Losses: -13982000.00
CYRX income_statement (annual, 2024-12-31) — Operating Income: -57862000.00
CYRX income_statement (annual, 2024-12-31) — Operating Revenue: 156769000.00
CYRX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 49908254.00
CYRX balance_sheet (annual, 2024-12-31) — Other Current Assets: 7943000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 14441000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Other Current Borrowings: 14441000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 18243000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 18243000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -20929000.00
CYRX income_statement (annual, 2024-12-31) — Other Income Expense: -42510000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 147927000.00
CYRX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 5855000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 70699000.00
CYRX balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 70699000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4046000.00
CYRX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -7101000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Properties: 59791000.00
CYRX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 216460000.00
CYRX income_statement (annual, 2024-12-31) — Other Special Charges: -18505000.00
CYRX income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CYRX balance_sheet (annual, 2024-12-31) — Payables: 15895000.00
CYRX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 24175000.00
CYRX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2929000.00
CYRX balance_sheet (annual, 2024-12-31) — Preferred Stock: 34275000.00
CYRX income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 8000000.00
CYRX balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 34275000.00
CYRX income_statement (annual, 2024-12-31) — Pretax Income: -104349000.00
CYRX cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2790000.00
CYRX cash_flow (annual, 2024-12-31) — Purchase Of Business: -313000.00
CYRX cash_flow (quarterly, 2024-12-31) — Purchase Of Business: -18000.00
CYRX cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -4013000.00
CYRX cash_flow (annual, 2024-12-31) — Purchase Of Investment: -50721000.00
CYRX cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
CYRX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -17254000.00
CYRX balance_sheet (annual, 2024-12-31) — Receivables: 25304000.00
CYRX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 87112000.00
CYRX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 30757000.00
CYRX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -164321000.00
CYRX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CYRX income_statement (annual, 2024-12-31) — Research And Development: 17710000.00
CYRX balance_sheet (annual, 2024-12-31) — Retained Earnings: -757175000.00
CYRX cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CYRX cash_flow (annual, 2024-12-31) — Sale Of Investment: 249116000.00
CYRX income_statement (annual, 2024-12-31) — Selling General And Administration: 109809000.00
CYRX balance_sheet (annual, 2024-12-31) — Share Issued: 49908254.00
CYRX income_statement (annual, 2024-12-31) — Special Income Charges: -45304000.00
CYRX income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CYRX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 19704000.00
CYRX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 401898000.00
CYRX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 199127000.00
CYRX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -7435890.00
CYRX income_statement (annual, 2024-12-31) — Tax Provision: 359000.00
CYRX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (annual, 2024-12-31) — Total Assets: 703492000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Capitalization: 586931000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Debt: 242539000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 401898000.00
CYRX income_statement (annual, 2024-12-31) — Total Expenses: 214631000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 301594000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 361921000.00
CYRX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 237031000.00
CYRX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -121671000.00
CYRX income_statement (annual, 2024-12-31) — Total Unusual Items: -35409000.00
CYRX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -35409000.00
CYRX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 899000.00
CYRX balance_sheet (annual, 2024-12-31) — Working Capital: 277008000.00
CYRX income_statement (quarterly, 2025-03-31) — +Operating Expense: 25835000.00
CYRX income_statement (quarterly, 2025-03-31) — +Total Revenue: 41040000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 13442000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 28371000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1147380000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -800000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 108090000.00
CYRX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 49947012.00
CYRX income_statement (quarterly, 2025-03-31) — Basic EPS: -0.28
CYRX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 45289000.00
CYRX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4078000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 42860000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 36325000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 36102000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 244031000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3157000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 32945000.00
CYRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -189000.00
CYRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 5922000.00
CYRX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -4342000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -783000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1633000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Inventory: -2305000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1288000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 673000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Payable: -783000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 850000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 227000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Receivables: 778000.00
CYRX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1065000.00
CYRX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 778000.00
CYRX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1391000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Common Stock: 50000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 362536000.00
CYRX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 22399000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Assets: 411276000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 4001000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Debt: 14475000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 18476000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1774000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1774000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 74030000.00
CYRX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 7646000.00
CYRX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 7646000.00
CYRX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 49947012.00
CYRX income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.28
CYRX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -13981000.00
CYRX income_statement (quarterly, 2025-03-31) — EBIT: -5921000.00
CYRX income_statement (quarterly, 2025-03-31) — EBITDA: 1725000.00
CYRX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 681000.00
CYRX cash_flow (quarterly, 2025-03-31) — End Cash Position: 47361000.00
CYRX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -189000.00
CYRX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -8420000.00
CYRX cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 851000.00
CYRX cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 4000.00
CYRX income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 1573000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -15738000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Goodwill: 20960000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 166374000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 29171000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 119583000.00
CYRX income_statement (quarterly, 2025-03-31) — Gross Profit: 18641000.00
CYRX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 408000.00
CYRX income_statement (quarterly, 2025-03-31) — Interest Expense: 583000.00
CYRX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 583000.00
CYRX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 36000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Inventory: 23340000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 562344000.00
CYRX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 5922000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Liabilities Heldfor Sale Non Current: 0.00
CYRX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 38859000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 185333000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 224192000.00
CYRX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -192000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Net Debt: 163706000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income: -11981000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -13981000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -6738000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -5243000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -11981000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -6738000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -11981000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -11981000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -910000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Interest Income: -583000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 10000000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -192000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -192000.00
CYRX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -583000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Net PPE: 119583000.00
CYRX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -3168000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 232437000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 614000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 878000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 614000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 878000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 1997000.00
CYRX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 152000.00
CYRX income_statement (quarterly, 2025-03-31) — Normalized Income: -7980670.00
CYRX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -4342000.00
CYRX cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 855000.00
CYRX income_statement (quarterly, 2025-03-31) — Operating Income: -7194000.00
CYRX income_statement (quarterly, 2025-03-31) — Operating Revenue: 41040000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 50137218.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 7444000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 14475000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 27657000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -15738000.00
CYRX income_statement (quarterly, 2025-03-31) — Other Income Expense: 1273000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 145414000.00
CYRX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -2838000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1933000.00
CYRX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -300000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Properties: 119583000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 207929000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Payables: 13442000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 13442000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12681000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 36275000.00
CYRX income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 2000000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 36275000.00
CYRX income_statement (quarterly, 2025-03-31) — Pretax Income: -6504000.00
CYRX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 3000.00
CYRX cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -910000.00
CYRX cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CYRX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -3168000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Receivables: 28371000.00
CYRX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 22399000.00
CYRX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7646000.00
CYRX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -192000.00
CYRX income_statement (quarterly, 2025-03-31) — Research And Development: 3934000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -769156000.00
CYRX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 10000000.00
CYRX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 21901000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Share Issued: 50137218.00
CYRX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 3700000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 398811000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 196162000.00
CYRX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 330330.00
CYRX income_statement (quarterly, 2025-03-31) — Tax Provision: 234000.00
CYRX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (quarterly, 2025-03-31) — Total Assets: 699844000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 584144000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Debt: 242668000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 398811000.00
CYRX income_statement (quarterly, 2025-03-31) — Total Expenses: 48234000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 301033000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 288568000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 227003000.00
CYRX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -7194000.00
CYRX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1573000.00
CYRX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1573000.00
CYRX cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -659000.00
CYRX balance_sheet (quarterly, 2025-03-31) — Working Capital: 337246000.00
CYRX income_statement (quarterly, 2025-06-30) — +Operating Expense: 31026000.00
CYRX income_statement (quarterly, 2025-06-30) — +Total Revenue: 45454000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 14756000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 33409000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1150700000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -900000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 0.00
CYRX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 50257112.00
CYRX income_statement (quarterly, 2025-06-30) — Basic EPS: 2.05
CYRX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 47361000.00
CYRX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6201000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 42691000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 38325000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 243416000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 425975000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 204477000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Cash Financial: 38939000.00
CYRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -15864000.00
CYRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 230039000.00
CYRX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -7345000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -1811000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -3201000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 638000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1647000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 923000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Payable: -1811000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -5012000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 2791000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Receivables: -6723000.00
CYRX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9030000.00
CYRX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -6723000.00
CYRX cash_flow (quarterly, 2025-06-30) — Changes In Cash: 206830000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Common Stock: 50000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 477116000.00
CYRX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 24077000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Assets: 489490000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 4316000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4316000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1677000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1677000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 30149000.00
CYRX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7296000.00
CYRX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7296000.00
CYRX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 50257112.00
CYRX income_statement (quarterly, 2025-06-30) — Diluted EPS: 2.05
CYRX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 103180000.00
CYRX income_statement (quarterly, 2025-06-30) — EBIT: -11122000.00
CYRX income_statement (quarterly, 2025-06-30) — EBITDA: -3826000.00
CYRX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -10775000.00
CYRX cash_flow (quarterly, 2025-06-30) — End Cash Position: 243416000.00
CYRX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -15864000.00
CYRX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -13546000.00
CYRX cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 1037000.00
CYRX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 101000.00
CYRX income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 1466000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -5399000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Goodwill: 18713000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 162303000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 34309000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 119771000.00
CYRX income_statement (quarterly, 2025-06-30) — Gross Profit: 21377000.00
CYRX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 218000.00
CYRX income_statement (quarterly, 2025-06-30) — Interest Expense: 618000.00
CYRX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 618000.00
CYRX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 885000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Inventory: 23035000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 662948000.00
CYRX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 230039000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Liabilities Heldfor Sale Non Current: 0.00
CYRX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 38375000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 185832000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 224207000.00
CYRX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -14552000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income: 105180000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 103180000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -12014000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 117194000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 105180000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -12014000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 105180000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 105180000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -1850000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Interest Income: -618000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 26001000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -14552000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -14552000.00
CYRX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -618000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Net PPE: 119771000.00
CYRX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -4351000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 353088000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 267000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 985000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 267000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 985000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 2096000.00
CYRX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -5292000.00
CYRX income_statement (quarterly, 2025-06-30) — Normalized Income: -13172140.00
CYRX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -7345000.00
CYRX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -115524000.00
CYRX income_statement (quarterly, 2025-06-30) — Operating Income: -9649000.00
CYRX income_statement (quarterly, 2025-06-30) — Operating Revenue: 45454000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 50278559.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 7071000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -5399000.00
CYRX income_statement (quarterly, 2025-06-30) — Other Income Expense: -1473000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 143590000.00
CYRX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2312000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3195000.00
CYRX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2939000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Properties: 119771000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 182559000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Payables: 14756000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 14756000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 9400000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 38275000.00
CYRX income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 2000000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 38275000.00
CYRX income_statement (quarterly, 2025-06-30) — Pretax Income: -11740000.00
CYRX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 2947000.00
CYRX cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -1850000.00
CYRX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CYRX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -4351000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Receivables: 33409000.00
CYRX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 24077000.00
CYRX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7296000.00
CYRX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -14552000.00
CYRX income_statement (quarterly, 2025-06-30) — Research And Development: 4118000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -668235000.00
CYRX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 26001000.00
CYRX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 26908000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Share Issued: 50278559.00
CYRX income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CYRX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2375000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 515391000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 314813000.00
CYRX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 307860.00
CYRX income_statement (quarterly, 2025-06-30) — Tax Provision: 274000.00
CYRX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (quarterly, 2025-06-30) — Total Assets: 773927000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 701223000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Debt: 228523000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 515391000.00
CYRX income_statement (quarterly, 2025-06-30) — Total Expenses: 55103000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 258536000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 284437000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 228387000.00
CYRX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -9649000.00
CYRX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 1466000.00
CYRX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 1466000.00
CYRX cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 46000.00
CYRX balance_sheet (quarterly, 2025-06-30) — Working Capital: 459341000.00
CYRX income_statement (quarterly, 2025-06-30) — Write Off: 0.00
CYRX income_statement (quarterly, 2025-09-30) — +Operating Expense: 31257000.00
CYRX income_statement (quarterly, 2025-09-30) — +Total Revenue: 44233000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 13884000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 34914000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1152249000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1000000.00
CYRX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CYRX balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
CYRX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 50125268.00
CYRX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.18
CYRX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 243416000.00
CYRX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4282000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 44770000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 40325000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 255811000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 421314000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 216467000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Cash Financial: 39344000.00
CYRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -2868000.00
CYRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 14306000.00
CYRX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 2188000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -129000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 1359000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -421000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1032000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -530000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Payable: -129000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1230000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 1318000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -1883000.00
CYRX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1318000.00
CYRX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -1883000.00
CYRX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 13626000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Common Stock: 50000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 472996000.00
CYRX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -3745000.00
CYRX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 22908000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Assets: 484843000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 4554000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 4554000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1447000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1447000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 30749000.00
CYRX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 6415000.00
CYRX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6415000.00
CYRX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 50125268.00
CYRX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.18
CYRX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -8943000.00
CYRX income_statement (quarterly, 2025-09-30) — EBIT: -6005000.00
CYRX income_statement (quarterly, 2025-09-30) — EBITDA: 410000.00
CYRX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -1231000.00
CYRX cash_flow (quarterly, 2025-09-30) — End Cash Position: 255811000.00
CYRX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -2868000.00
CYRX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2094000.00
CYRX cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 395000.00
CYRX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of Business: -3385000.00
CYRX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 44000.00
CYRX income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 3402000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -4068000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Goodwill: 22409000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 163663000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 35914000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 123457000.00
CYRX income_statement (quarterly, 2025-09-30) — Gross Profit: 21325000.00
CYRX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 308000.00
CYRX income_statement (quarterly, 2025-09-30) — Interest Expense: 526000.00
CYRX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 526000.00
CYRX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 4000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Inventory: 23326000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 659086000.00
CYRX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 14306000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Liabilities Heldfor Sale Non Current: 0.00
CYRX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 40216000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 186090000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 226306000.00
CYRX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -146000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -3745000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income: -6943000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -8943000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -6696000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -247000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -6943000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -6696000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -3254000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -6943000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: -829000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Interest Income: -526000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 18588000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -146000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -146000.00
CYRX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -526000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Net PPE: 123457000.00
CYRX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -3453000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 349608000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 268000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 664000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 268000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 664000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 2097000.00
CYRX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2992000.00
CYRX income_statement (quarterly, 2025-09-30) — Normalized Income: -9383580.00
CYRX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 2188000.00
CYRX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -2946000.00
CYRX income_statement (quarterly, 2025-09-30) — Operating Income: -9932000.00
CYRX income_statement (quarterly, 2025-09-30) — Operating Revenue: 44233000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 50068904.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5289000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -4068000.00
CYRX income_statement (quarterly, 2025-09-30) — Other Income Expense: 3927000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 141254000.00
CYRX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1815000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 3338000.00
CYRX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 525000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Properties: 123457000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 165503000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Payables: 13884000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 13884000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 10864000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 40275000.00
CYRX income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 2000000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 40275000.00
CYRX income_statement (quarterly, 2025-09-30) — Pretax Income: -6531000.00
CYRX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1023000.00
CYRX cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -829000.00
CYRX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CYRX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -3453000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Receivables: 34914000.00
CYRX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 22908000.00
CYRX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6415000.00
CYRX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -146000.00
CYRX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -3745000.00
CYRX income_statement (quarterly, 2025-09-30) — Research And Development: 4523000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -675235000.00
CYRX cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
CYRX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 18588000.00
CYRX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 26734000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Share Issued: 50068904.00
CYRX income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CYRX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2526000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 513271000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 309333000.00
CYRX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 714420.00
CYRX income_statement (quarterly, 2025-09-30) — Tax Provision: 165000.00
CYRX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CYRX balance_sheet (quarterly, 2025-09-30) — Total Assets: 774328000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 699361000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Debt: 230860000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 513271000.00
CYRX income_statement (quarterly, 2025-09-30) — Total Expenses: 54165000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 261057000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 289485000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 230308000.00
CYRX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -9932000.00
CYRX income_statement (quarterly, 2025-09-30) — Total Unusual Items: 3402000.00
CYRX income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 3402000.00
CYRX cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -1050000.00
CYRX balance_sheet (quarterly, 2025-09-30) — Working Capital: 454094000.00
CYRX income_statement (quarterly, 2025-09-30) — Write Off: 0.00
CYRX income_statement (annual, 2025-12-31) — +Operating Expense: 119860000.00
CYRX income_statement (quarterly, 2025-12-31) — +Operating Expense: 31742000.00
CYRX income_statement (annual, 2025-12-31) — +Total Revenue: 176177000.00
CYRX income_statement (quarterly, 2025-12-31) — +Total Revenue: 45450000.00
CYRX balance_sheet (annual, 2025-12-31) — Accounts Payable: 15283000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 15283000.00
CYRX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 33359000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 33359000.00
CYRX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -49483000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -49483000.00
CYRX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1152680000.00
CYRX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1152680000.00